Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Nov 26, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-19-000025.pdf 0001237899-19-000025.xls
Nov 22, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-19-000020.pdf 0001237899-19-000020.xls
Nov 13, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-19-000012.pdf 0001708138-19-000012.xls
Nov 12, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-19-000010.pdf 0001708138-19-000010.xls
Nov 08, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-19-000018.pdf 0001237899-19-000018.xls
Nov 05, 2019	8-K	Report of unscheduled material events or corporate event	View HTML 0001532176-19-000032.pdf 0001532176-19-000032.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Nov 05, 2019	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001532176-19-000034.pdf 0001532176-19-000034.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Oct 08, 2019	CT ORDER	CT ORDER	View HTML 9999999997-19-007250.pdf
Sep 12, 2019	4	Statement of changes in beneficial ownership of securities	View HTML 0001140361-19-016600.pdf 0001140361-19-016600.xls
Aug 06, 2019	8-K	Report of unscheduled material events or corporate event	View HTML 0001532176-19-000024.pdf 0001532176-19-000024.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.

Investors & Media